Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Felipe Rodriguez
Observed name:
Rodriguez, Felipe
Institution:
The University of Texas at El Paso
Observed institution:
The University of Texas at El Paso
ORCID:
0000-0003-1656-4989
Observed ORCID:
0000-0003-1656-4989
OpenAlex ID:
A5057917014
An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major
2017
·
Eva Iniguez
, Nathaniel S. Schocker
, et al.
·
PLoS neglected tropical diseases
·
56
PDF
Surveillance of Trypanosoma cruzi infection in Triatomine vectors, feral dogs and cats, and wild animals in and around El Paso county, Texas, and New Mexico
2021
·
Felipe Rodriguez
, Brenda S. Luna
, et al.
·
PLoS neglected tropical diseases
·
43
PDF
Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by Leishmania major
2018
·
Felipe Rodriguez
, Eva Iniguez
, et al.
·
Molecules
·
22
PDF
In Vitro and In Vivo Characterization of Potent Antileishmanial Methionine Aminopeptidase 1 Inhibitors
2020
·
Felipe Rodriguez
, Sarah F. John
, et al.
·
Antimicrobial Agents and Chemotherapy
·
18
Identification of Leishmania spp. and Trypanosoma cruzi in bats captured in El Paso County, Texas
2026
·
Juan C. Silva-Espinoza
, Priscila S. G. Farani
, et al.
·
PLoS neglected tropical diseases
·
3
PDF
Trypanosoma cruzi infection in a bat-eared fox (Otocyon megalotis) with severe focally extensive suppurative myocarditis
2021
·
Marc Andrew Charles Silpa
, Felipe Rodriguez
, et al.
·
Journal of Exotic Pet Medicine
·
1
Correction: Identification of Leishmania spp. and Trypanosoma cruzi in bats captured in El Paso County, Texas
2026
·
Juan C. Silva-Espinoza
, Priscila S. G. Farani
, et al.
·
PLoS neglected tropical diseases
Ligand-lytic peptides for specific targeting of Leishmania major and Trypanosoma cruzi parasites
2025
·
Eva Iniguez
, Felipe Rodriguez
, et al.
·
Frontiers in Cellular and Infection Microbiology
PDF
Synthetic glycovaccines elicit cross-protection against Chagas disease and tegumentary leishmaniasis in a murine co-infection model
2023
·
Colin D Knight
, Igor L Estevao
, et al.
·
The Journal of Immunology
PDF
Therapeutic activity of organotin compounds against Trypanosoma cruzi
2018
·
Alexis Dominique Mata
, Itzel Tejeda
, et al.
·
The FASEB Journal
Improving protection against visceral leishmaniasis by heterologous prime-boost vaccination based on DNA and insect-derived recombinant proteins
2011
·
Felicitat Todolí
, Alheli Rodríguez‐Cortés
, et al.
·
Tropical Medicine & International Health
Show more works
View as search
Works count:
14
Citation count:
143
H-index:
4
I10-index:
4
Year
Topic
Type